Tenderfy

Gene testing and reporting for Ovarian cancer specimens

Acheteur
NHS Greater Glasgow and Clyde
Publié
2026-11-19
Échéance
Non indiqué
Sources
UK_FTS
Valeur
Non indiqué

Description

La description est dans la langue de la source.

NHS Greater Glasgow and Clyde, Laboratory Genetics requires an end-to-end diagnostic service for FFPE block processing, DNA based Homologous Repair Deficiency (HRD) and BRCA1 and BRCA2 gene testing and reporting for Ovarian cancer specimens. This service is required for approximately 200 tests per annum and the service must be available by 1st December 2026.

CPV: 85145000

Abonnement

Consultez gratuitement les aperçus. Les liens vers les avis officiels et leurs documents, les permis de construire et l’accès MCP personnel nécessitent un abonnement payant actif.

Lire